The Co-Founder of Gossamer Bio, Inc. (NASDAQ:GOSS), Faheem Hasnain, Just Bought 3.8% More Shares
Gossamer Bio, Inc. (NASDAQ:GOSS) shareholders (or potential shareholders) will be happy to see that the Co-Founder, Faheem Hasnain, recently bought a whopping US$1m worth of stock, at a price of US$7.21. While that only increased their holding size by 3.8%, it is still a big swing by our standards.
Check out our latest analysis for Gossamer Bio
Gossamer Bio Insider Transactions Over The Last Year
Notably, that recent purchase by Faheem Hasnain is the biggest insider purchase of Gossamer Bio shares that we've seen in the last year. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$11.28. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.
In the last twelve months insiders purchased 166.43k shares for US$1.2m. On the other hand they divested 77.02k shares, for US$688k. Overall, Gossamer Bio insiders were net buyers during the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
Gossamer Bio is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
Does Gossamer Bio Boast High Insider Ownership?
Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Insiders own 12% of Gossamer Bio shares, worth about US$98m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
So What Do The Gossamer Bio Insider Transactions Indicate?
It is good to see recent purchasing. And an analysis of the transactions over the last year also gives us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Given that insiders also own a fair bit of Gossamer Bio we think they are probably pretty confident of a bright future. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For example, Gossamer Bio has 4 warning signs (and 1 which doesn't sit too well with us) we think you should know about.
Of course Gossamer Bio may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
